VERSANT VENTURE CAPITAL VI, L.P. sold 5.6% of their position (221.60K shares) of BLACK DIAMOND THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.40M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/30/2024ACC: 0000950170-24-102354
→
10% Owner
Since Jan 2020
-221.60K
Net shares
Net seller
$1.40M
Total sold
1
Open market trades
0B · 1S
1
Total transactions
221.60K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−221.60K
Price / share
$6.32
Trade value
$1.40M
% of position
5.6%
8/28/2024
3.95M→3.73M
Total
Net shares
−221.60K
Net value
-$1.40M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/28/2024 | S · Sale | −221.60K | $6.32 | $1.40M | 5.6% | 3.95M | 3.73M |
| Total | −221.60K | -$1.40M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Common Stock
IndirectShares owned1.28M
Common Stock
IndirectShares owned822.14K
Common Stock
IndirectShares owned380.94K
Total
2.48M indirect2.48M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.28M | Indirect |
| Common Stock | 822.14K | Indirect |
| Common Stock | 380.94K | Indirect |
| Total | 2.48M | 2.48M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported